City

Kilifi (3)

Condition

Malaria,Falciparum (3)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (2)

phase 2 (1)

Sponsor

University of Oxford (3)

Collaborator

Kenya Medical Research Institute (3)

European and Developing Countries Clinical Trials Partnership (EDCTP) (2)

KEMRI-Wellcome Trust Collaborative Research Program (1)

Sanaria Inc. (1)

Intervention

artemether lumefantrine (1)

chad63/mva me-trap (1)

intradermal injection (id) or direct venous injection (dvi) of pfspz challenge (1)

pfspz challenge (1)

piperaquine (1)

primaquine (1)

r21 in matrix- m adjuvant vaccine (1)

r21/matrix-m (1)

sulfadoxine-pyrimethamine (1)

Study Documents

Intervention Type

biological (3)

drug (1)

Funder Type

Other (3)

Study Type

Interventional (3)

Malaria,Falciparum

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Malaria,Falciparum Trial in Kilifi (R21/Matrix-M, ChAd63/MVA ME-TRAP, intradermal injection (ID) or direct venous injection

Recruiting

Malaria,Falciparum

R21/Matrix-M
+2 more

Kilifi, Kenya

KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine R

Sep 14, 2022

Malaria,Falciparum Trial in Kilifi (R21 in Matrix- M adjuvant vaccine)

Completed

Malaria,Falciparum

R21 in Matrix- M adjuvant vaccine

Kilifi, Kenya

KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine R

Aug 19, 2022

Malaria,Falciparum Trial in Kilifi (PfSPZ Challenge, Sulfadoxine-Pyrimethamine, Piperaquine)

Not yet recruiting

Malaria,Falciparum

PfSPZ Challenge
+4 more

Kilifi, Kenya

KEMRI-Wellcome Trust Research Programme

May 17, 2022